BioXcel's (BTAI) OnkosXcel Therapeutics Files for Proposed IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
OnkosXcel Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
March 14, 2023 4:15 PM EDTNEW HAVEN, Conn., March 14, 2023 (GLOBE NEWSWIRE) -- OnkosXcel Therapeutics, LLC (OnkosXcel) today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the SEC) relating to the proposed initial public offering of its common stock following its conversion into a corporation. The... More



